CD73 Antikörper PE (ABIN1176840)
Targeting CD73 to augment cancer immunotherapy - ScienceDirect
Biomedicines | Free Full-Text | A Novel Anti-CD73 Antibody That Selectively Inhibits Membrane CD73 Shows Antitumor Activity and Induces Tumor Immune Escape
CD73 Antikörper PE (ABIN1176840)
Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma | World Journal of Surgical Oncology | Full Text
Profound inhibition of CD73-dependent formation of anti-inflammatory adenosine in B cells of SLE patients - eBioMedicine
Flow cytometry analysis of cell surface markers CD90, CD73, and CD105... | Download Scientific Diagram
IJMS | Free Full-Text | The Clinical Significance of CD73 in Cancer
Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation | Cancer Immunology, Immunotherapy
Extracellular vesicles derived from CD73 modified human umbilical cord mesenchymal stem cells ameliorate inflammation after spinal cord injury | Journal of Nanobiotechnology | Full Text
Ecto‑5'‑nucleotidase (CD73) inhibits dorsal root ganglion neuronal apoptosis by promoting the Ado/cAMP/PKA/CREB pathway
CD73 antibody (Clone KK3) | ONCOdianova CD73 anti-human for IHC
Expression of stem cell markers in SHED: CD90, CD73, CD105, and... | Download Scientific Diagram
![Anti-CD73 Antikörper [AD2] (APC) (A121913) | Antibodies.com](https://cdn.antibodies.com/image/catalog/121/A121913_1.jpg?profile=product_top "Anti-CD73 Antikörper [AD2] (APC) (A121913) | Antibodies.com")
Anti-CD73 Antikörper [AD2] (APC) (A121913) | Antibodies.com
Frontiers | Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy
CD73 Antikörper PE (ABIN1176840)
CD73 Expression on Mesenchymal Stem Cells Dictates the Reparative Properties via Its Anti-Inflammatory Activity
CD73-mediated adenosine production by CD8 T cell-derived extracellular vesicles constitutes an intrinsic mechanism of immune suppression | Nature Communications
Targeting CD73 to augment cancer immunotherapy - ScienceDirect
Frontiers | Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy
Positive expression of mesenchymal stem cell markers (CD105, CD73,... | Download Scientific Diagram
Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents | Journal for ImmunoTherapy of Cancer
CD73 Promotes Glioblastoma Pathogenesis and Enhances Its Chemoresistance via A2B Adenosine Receptor Signaling | Journal of Neuroscience
The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition | Journal of Cancer Research and Clinical Oncology
IJMS | Free Full-Text | CD73: Friend or Foe in Lung Injury
Osteoblasts express more CD73 than MSCs. The expression of MSC cell... | Download Scientific Diagram
